With Kevin watching, Keelan Harvick earned the biggest Late Model win of his young career at Five Flags Speedway in Pensacola ...
What do you think? Does this Audi deserve better than to be compared to its peers? Or does it simply need a lower price to ...
In Indiaβs commuter-bike segment, the 125cc class offers a sweet spot for riders who want a blend of performance and efficiency without overshooting the budget. For under Rs 1 lakh, you can now get ...
Hero MotoCorp has launched a new variant of the Xtreme 125R in the Indian market at a starting price of Rs 1.04 lakh (ex-showroom). This iteration of the motorcycle comes with multiple changes in ...
Itβs now the safest 125cc sporty commuter bike in the country Hero has pulled a proper stealth move β the Xtreme 125R has gotten a brand new fully-loaded variant loaded, which is priced at Rs 1,04,500 ...
Hero Xtreme 125R is going to be updated for the Indian market. Before the official launch, the motorcycle is already reaching dealerships in the country, and the spy shots of the machine have been ...
This Vespa has been a symbol of freedom and independence for the past 10 years β a true city companion. Purchased in 2015 through BikeSales, originally linked to Gasoline Motor Co. in Alexandria, and ...
As University of Missouri and University of Alabama fans unpacked tents and coolers from their cars on Saturday, Oct. 11, a group of 25 students assembled outside the Student Center armed with rolls ...
The revised GST structure has reduced the tax rate on motorcycles under 350cc from 28 percent to 18 percent, making bikes in the 125cc segment significantly more affordable. Popular models like the ...
It's no secret that Yamaha's 125cc engine has a long, prestigious history. Rolled out shortly after the company's founding in February 1955, it powered Yamaha's first-ever motorcycle, the YA-1, to ...
The first major difference between the two motorcycles is in terms of the design. The Hero Glamour X 125 is a premium commuter and it takes inspiration from the Glamour Xtec model to a great extent.
TT125-802 targets transcriptional pathways in NSCLC with EGFR or KRAS-G12C mutations, addressing resistance to current therapies. The therapy has shown promising single-agent activity and a favorable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results